ArticleProceedings of the National Academy of Sciences of the United States of America2019

My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer.

Alexander Levitzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.